在类风湿性关节炎免疫性突触中STAT3酸化
Hila Novak Kotzer1,2, Jesusa Capera2, Ashwin Jainarayanan2
1Skirball Institute of Biomolecular Medicine, NYU Langone Medical Center, New York, NY 10016 USA.
bioRxiv : the preprint server for biology
|February 3, 2025
概括
研究人员发现了一种新的方式,STAT3 (信号转换器和转录激活器3) 在T细胞中被激活,独立于JAK抑制剂. 这一发现为现有治疗方法耐药的风湿性关节炎 (RA) 患者提供了新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 类风湿病学 类风湿病学
背景情况:
- JAK/STAT通路是类风湿性关节炎 (RA) 的首要治疗标.
- 雅克抑制剂是有效的,但一些RA患者对它们没有反应,需要使用替代策略.
- 在RA的发病过程中,STAT3的激活至关重要,但其在JAK信号之外的调节还没有完全被理解.
研究的目的:
- 识别T细胞中STAT3激活的新型,JAK独立的机制.
- 研究免疫突触 (IS) 在STAT3激活中的作用.
- 探索针对这种新途径治疗RA的潜力.
主要方法:
- 在免疫突触形成时,研究了原始CD4+T细胞中的STAT3激活.
- 利用技术来评估T细胞受体 (TCR) 依赖的信号传递.
- 在IS分析了Lck激酶在STAT3酸化中的作用.
- 在RA患者和健康对照中比较突触Lck/TCR-STAT3通路活性.
主要成果:
- 通过免疫突触形成启动的STAT3激活的新型JAK独立途径.
- 证明Lck在T细胞的IS中调解TCR依赖的STAT3酸化.
- 表明这种突触Lck/TCR-STAT3通路在类风湿性关节炎中受损.
- 突出了早期T细胞激活的以前未知的机制.
结论:
- 存在一种新的JAK-独立的STAT3激活机制,在T细胞激活过程中由Lck在免疫突触中介.
- 在类风湿性关节炎中,突触Lck/TCR-STAT3通路受到损害.
- 这一途径代表了RA的潜在新疗法标,特别是对于抗JAK抑制剂耐药的患者.
关键词:
CD4 T 细胞是 CD4 的 T 细胞.免疫学的突触.雅克抑制剂 雅克抑制剂哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈类风湿性关节炎 类风湿性关节炎 类风湿性关节炎在STAT3中,我们可以使用STAT3.更多相关视频
09:18Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
7.2K
04:49Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
73
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
T Cell Types and Functions
939
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
939
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
